21-hydroxypregnenolone (BioDeep_00000005846)
Main id: BioDeep_00000637522
human metabolite PANOMIX_OTCML-2023 Endogenous blood metabolite natural product
代谢物信息卡片
化学式: C21H32O3 (332.2351322)
中文名称: 21-羟基孕烯醇酮
谱图信息:
最多检出来源 () 0%
Last reviewed on 2024-09-13.
Cite this Page
21-hydroxypregnenolone. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China.
https://query.biodeep.cn/s/21-hydroxypregnenolone_disulfate (retrieved
2024-11-08) (BioDeep RN: BioDeep_00000005846). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
分子结构信息
SMILES: CC12CCC(O)CC1=CCC1C2CCC2(C)C(C(=O)CO)CCC12
InChI: InChI=1S/C21H32O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h3,14-18,22-23H,4-12H2,1-2H3/t14-,15-,16-,17-,18+,20-,21-/m0/s1
描述信息
21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by human adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in human. (PMID 974176, 3347051, 3495701, 7382480, 6247575) [HMDB]
21-hydroxypregnenolone is an essential intermediate in corticosterone synthesis. The hydrolysis of 21-hydroxypregnenolone of fetal origin by steryl-sulfatase (SOS, EC 3.1.6.2), may be important in the biosynthesis of deoxycorticosterone, which is present in the plasma of pregnant women in high concentration. 21-hydroxypregnenolone has been identified in follicular fluid from follicles of women. Pregnenolone is transformed to 21-hydroxypregnenolone by human adrenal microsomal preparations, suggesting the involvement of alternative paths via 17a,21-dihydroxypregnenolone in human. (PMID 974176, 3347051, 3495701, 7382480, 6247575).
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
21-Hydroxypregnenolone. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=1164-98-3 (retrieved 2024-07-16) (CAS RN: 1164-98-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
21-Hydroxypregnenolone is an essential intermediate in corticosterone synthesis.
同义名列表
16 个代谢物同义名
2-hydroxy-1-[(8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 2-hydroxy-1-[(1S,2R,5S,10S,11S,14S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-14-yl]ethan-1-one; Pregn-5-en-20-one,3,21-dihydroxy-, (3b)-; (3beta)-3,21-dihydroxypregn-5-en-20-one; (3b)-3,21-Dihydroxy-pregn-5-en-20-one; (3b)-3,21-Dihydroxypregn-5-en-20-one; (3Β)-3,21-dihydroxypregn-5-en-20-one; 3beta,21-dihydroxypregn-5-en-20-one; 3b,21-Dihydroxy-pregn-5-en-20-one; 5-Pregnen-3.beta.,21-diol-20-one; 3b,21-Dihydroxy-5-pregnen-20-one; 5-Pregnen-3beta,21-diol-20-one; Pregn-5-ene-3b,21-diol-20-one; 5-Pregnen-3b,21-diol-20-one; 21-hydroxypregnenolone; Oprea1_642453
数据库引用编号
17 个数据库交叉引用编号
- ChEBI: CHEBI:28043
- KEGG: C05485
- PubChem: 247020
- HMDB: HMDB0004026
- Metlin: METLIN7002
- ChEMBL: CHEMBL1908012
- Wikipedia: 21-Hydroxypregnenolone
- foodb: FDB023281
- chemspider: 216208
- CAS: 1164-98-3
- PMhub: MS000018742
- LipidMAPS: LMST02030167
- 3DMET: B05059
- NIKKAJI: J924.614B
- RefMet: 21-Hydroxypregnenolone
- medchemexpress: HY-113020
- LOTUS: LTS0093663
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
34 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(34)
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Steroidogenesis:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 17-alpha-Hydroxylase Deficiency (CYP17):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 11-beta-Hydroxylase Deficiency (CYP11B1):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 21-Hydroxylase Deficiency (CYP21):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase I Deficiency (CMO I):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Corticosterone Methyl Oxidase II Deficiency (CMO II):
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- Apparent Mineralocorticoid Excess Syndrome:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
- 3-beta-Hydroxysteroid Dehydrogenase Deficiency:
Cortexolone + Oxygen + Reduced adrenal ferredoxin ⟶ Cortisol + Oxidized adrenal ferredoxin + Water
PharmGKB(0)
9 个相关的物种来源信息
- 7711 - Chordata: LTS0093663
- 2759 - Eukaryota: LTS0093663
- 9606 - Homo sapiens: -
- 40674 - Mammalia: LTS0093663
- 33208 - Metazoa: LTS0093663
- 10066 - Muridae: LTS0093663
- 10088 - Mus: LTS0093663
- 10090 - Mus musculus: LTS0093663
- 10090 - Mus musculus: NA
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Changzhuan Shao, Yiming Ren, Zinan Wang, Chenzhe Kang, Hongke Jiang, Aiping Chi. Detection of Urine Metabolites in a Rat Model of Chronic Fatigue Syndrome before and after Exercise.
BioMed research international.
2017; 2017(?):8182020. doi:
10.1155/2017/8182020
. [PMID: 28421200] - A Guerami, M W Varner, C H Shackleton, P C MacDonald, M L Casey. Origin of deoxycorticosterone and deoxycorticosterone sulfate in human pregnancy: absence of steroid 21-sulfatase activity in sulfatase-deficient placenta.
Journal of steroid biochemistry.
1988 Jan; 29(1):57-62. doi:
10.1016/0022-4731(88)90376-7
. [PMID: 3347051] - L Dehennin, K Nahoul, R Scholler. Steroid 21-hydroxylation by human preovulatory follicles from stimulated cycles: a mass spectrometrical study of deoxycorticosterone, 21-hydroxypregnenolone and 11-deoxycortisol in follicular fluid.
Journal of steroid biochemistry.
1987 Mar; 26(3):337-43. doi:
10.1016/0022-4731(87)90098-7
. [PMID: 3495701]